TBX3 Promotes Melanoma Migration by Transcriptional Activation of ID1, which Prevents Activation of E-Cadherin by MITF.


Journal

The Journal of investigative dermatology
ISSN: 1523-1747
Titre abrégé: J Invest Dermatol
Pays: United States
ID NLM: 0426720

Informations de publication

Date de publication:
09 2021
Historique:
received: 14 09 2020
revised: 22 01 2021
accepted: 09 02 2021
pubmed: 22 3 2021
medline: 15 12 2021
entrez: 21 3 2021
Statut: ppublish

Résumé

In melanoma, a phenotype switch from proliferation to invasion underpins metastasis, the major cause of melanoma-associated death. The transition from radial to vertical growth phase (invasive) melanoma is characterized by downregulation of both E-cadherin (CDH1) and MITF and upregulation of the key cancer-associated gene TBX3 and the phosphatidylinositol 3 kinase signaling pathway. Yet, whether and how these diverse events are linked remains poorly understood. Here, we show that TBX3 directly promotes expression of ID1, a dominant-negative regulator of basic helix-loop-helix transcription factors, and that ID1 decreases MITF binding and upregulation of CDH1. Significantly, we show that TBX3 activation of ID1 is necessary for TBX3 to enhance melanoma cell migration, and the mechanistic links between TBX3, ID1, MITF, and invasion revealed here are reflected in their expression in human melanomas. Our results reveal that melanoma migration is promoted through a TBX3-ID1-MITF-E-cadherin axis and that ID1-mediated repression of MITF activity may reinforce maintenance of an MITF

Identifiants

pubmed: 33744299
pii: S0022-202X(21)01001-0
doi: 10.1016/j.jid.2021.02.740
pii:
doi:

Substances chimiques

Cadherins 0
ID1 protein, human 0
Inhibitor of Differentiation Protein 1 0
Microphthalmia-Associated Transcription Factor 0
T-Box Domain Proteins 0
TBX3 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2250-2260.e2

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Jade Peres (J)

Department of Human Biology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

Victoria Damerell (V)

Department of Human Biology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

Jagat Chauhan (J)

Ludwig Institute for Cancer Research, University of Oxford, Nuffield Department of Clinical Medicine, Oxford United Kingdom.

Ana Popovic (A)

Department of Human Biology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

Pierre-Yves Desprez (PY)

California Pacific Medical Center, Research Institute, San Francisco, California, USA.

Marie-Dominique Galibert (MD)

IGDR (Institut de Génétique et Développement de Rennes) - UMR6290, CNRS, University of Rennes, Rennes, France; Department of Molecular Genetics and Genomics, Hospital University of Rennes (CHU Rennes), Rennes, France.

Colin R Goding (CR)

Ludwig Institute for Cancer Research, University of Oxford, Nuffield Department of Clinical Medicine, Oxford United Kingdom.

Sharon Prince (S)

Department of Human Biology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. Electronic address: sharon.prince@uct.ac.za.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH